Malignant Melanoma
📧 Sign up to get email alerts when something new happens for Malignant Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma [Phase 1]
Phase 1 clinical trial evaluating safety and feasibility of combining bortezomib (PS-341) with interferon-alpha-2b in patients with malignan…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: NAM-Trial: Multiferon in Malignant Melanoma [Phase 2]
A Phase 2 clinical trial update for Multiferon in malignant melanoma with locoregional metastases (stages IIIB/C) has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma [Phase 1, Phase 2]
This document reports an update on a Phase 1/2 trial evaluating a telomerase peptide vaccine in combination with temozolomide for advanced m…
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma [Phase 1]
Phase 1 study evaluating peptide vaccination in combination with ipilimumab or vemurafenib for unresectable stage III or IV malignant melano…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Phase II Trial of Ontak With Metastatic Melanoma [Phase 2]
Phase II trial evaluating Ontak (denileukin diftitox) in metastatic melanoma has completed, with results posted in 2014. The update summariz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy of a docetaxel and carboplatin combination in metastatic malignant melanoma patients who fa…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) in combination with fotemustine for metastatic melanoma completed with results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma [Phase 2]
Phase 2 trial evaluating ramucirumab (IMC-1121B) with or without dacarbazine in metastatic malignant melanoma has completed and posted its r…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma [Phase 3]
Phase 3 trial comparing ABI-007 to dacarbazine in previously untreated metastatic malignant melanoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma [Phase 2]
A Phase 2 continuation booster trial using a peptide vaccine targeting melanoma antigens (tyrosinase, GP100, MART-1) emulsified with Montani…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study [Phase 2]
A Phase II study evaluated Abraxane in combination with Avastin in patients with metastatic malignant melanoma, with results posted after tr…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma [Phase 3]
Phase 3 trial evaluating dacarbazine with or without oblimersen in advanced malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301 [NA]
A clinical trial update on oblimersen plus dacarbazine for advanced malignant melanoma that previously responded to treatment in the GENTA-G…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Malignant Melanoma [Phase 2]
A Phase 2 clinical trial evaluating a vaccine therapy for malignant melanoma is underway. The current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma [Phase 2]
A multicenter Phase 2 dose-finding trial of CP-4055 in combination with sorafenib for metastatic malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients [Phase 2]
Phase 2 study evaluating a dendritic cell vaccine with or without cyclophosphamide for stage IV malignant melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma [Phase 2]
Phase 2 trial of tanespimycin (17-AAG) for metastatic malignant melanoma has completed. Sponsor: Cancer Research UK.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating a vaccine therapy with or without interleukin-2 for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases [Phase 2]
Phase 2 trial S9903 evaluating whole brain radiotherapy followed by stereotactic radiosurgery for limited melanoma brain metastases; the tri…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma [NA]
A completed clinical trial evaluating a vaccine therapy plus sargramostim in patients with stage IV malignant melanoma.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma [Phase 2]
Phase 2 trial evaluating bevacizumab and sorafenib in unresectable stage III or stage IV malignant melanoma has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: PS-341 in Treating Patients With Metastatic Malignant Melanoma [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating PS-341 (bortezomib) in patients with recurrent or stage IV malignant melanom…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating a tumor mRNA vaccine in metastatic melanoma, comparing a fixed combination of targeted antig…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 [Phase 1, Phase 2]
This clinical trial update reports completion of a Phase 1/Phase 2 study evaluating local treatment of metastatic melanoma using autologous …
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression [Phase 2]
The document provides an update on the Phase 2 efficacy study of the investigational drug P276-00 in Cyclin D1-positive malignant melanoma; …